ArticleBlood2014
Ras pathway mutations are prevalent in relapsed childhood acute lymphoblastic leukemia and confer sensitivity to MEK inhibition.
Julie Irving et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
151 papers cite itlatest 60 shown
this papertrialcites it